|
[Related PubMed/MEDLINE] Total Number of Papers: 130
|
|
|
[Display Entries]
|
>> all entries
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer. |
SBRT |
2 |
2020 |
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial. |
CFI, EGFR, ESCC |
3 |
2020 |
Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China. |
ESCC, IFI, LRFS, MFS, OS, PFS |
4 |
2020 |
Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer. |
CRT, ESCC, IFI |
5 |
2020 |
Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study. |
CCRT, IENF, IFRT, NSCLC, PSM |
6 |
2020 |
Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation. |
AEs, AFRT, CRT, GC, HFRT |
7 |
2020 |
Elective Nodal Irradiation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns. |
LS-SCLC |
8 |
2020 |
Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. |
ESCC, LNM |
9 |
2020 |
Intensity-Modulated Radiation Therapy for Esthesioneuroblastoma: 10-Year Experience of a Single Institute. |
DMFS, ENB, IMRT, LPFS, OS, PFS, RPFS |
10 |
2020 |
Neck management in patients with olfactory neuroblastoma. |
ONB, PFS |
11 |
2020 |
SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach. |
B-ENI, cRF, HNSCC, HRQoL |
12 |
2019 |
A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer. |
CTV, DLT, MTD, SIB |
13 |
2019 |
Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation. |
CI, ESCC, IFI, IMRT, LN, OS, PSM |
14 |
2019 |
Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis. |
CIs, EAC, EC, ESCC, HR, IFI, nCRTS, nCRTS-ENI, nCRTS-IFI, nCTS, OS, RCTs |
15 |
2019 |
Incidence of contralateral regional failure in the electively irradiated contralateral neck of patients with head and neck squamous cell carcinoma. |
cRF, HNSCC, iRF, RF |
16 |
2019 |
Involved-field irradiation for elderly bladder cancer patients. |
IFI |
17 |
2019 |
Management of clinically negative neck in salivary gland cancers - elective neck dissection, irradiation, or surveillance? |
DFS, END, OS |
18 |
2019 |
Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial. |
cRF, HNSCC |
19 |
2019 |
Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16). |
BCS, DFS, HER2, LRC, NAC, OS, pCR |
20 |
2019 |
SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation. |
BF, PCa, PSA, SABR |
21 |
2019 |
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Middle or Lower Esophageal Cancer Using Elective Nodal Irradiation: Comparison with 3D Conformal Radiotherapy. |
MLD, PTV, SIB, V20Gy, V5Gy, VMAT |
22 |
2019 |
SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models. |
HNSCC, NTCP |
23 |
2019 |
Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. |
AEs, CI, CRT, IF, LA-NSCLC, TRT |
24 |
2019 |
What Is the Optimal Radiotherapy Target Size for Non-Operable Esophageal Cancer? A Meta-Analysis. |
IFI, OR |
25 |
2018 |
Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis. |
ESCC, IFI |
26 |
2018 |
Elective Management of the Neck in Parotid Tumours. |
END |
27 |
2018 |
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy. |
DLN, ICB |
28 |
2018 |
Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients. |
CI, CR, ESCC, IFI, OS |
29 |
2018 |
Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for StageIIINSCLC. |
BED, CI, CRT, HRs, IF-TRT, LA-NSCLC, TRT |
30 |
2018 |
Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience. |
DFS, PORT, RC, SMGC |
31 |
2018 |
Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control. |
DFS, ESD, LC, RT |
32 |
2018 |
SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma. |
HNSCC, LDM |
33 |
2017 |
An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result. |
CSS, DMFS, IMRT, LC, NPC, OS, PFS, RC |
34 |
2017 |
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis. |
IFI |
35 |
2017 |
Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature. |
CCRT |
36 |
2017 |
Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity. |
HNSCC, IRR |
37 |
2017 |
Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer. |
CFI |
38 |
2017 |
Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer. |
CEC, DMFS, GTV, IFI, IMRT, LRFFS, OS, PFS, RLN, RT, VMAT |
39 |
2017 |
Radiotherapy for T3N0 glottic carcinoma without cord fixation: elective nodal irradiation or not? |
CRT, CTV, UICC |
40 |
2017 |
Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. |
RCHT, SCLC, SNI |
41 |
2016 |
Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer. |
3D-CRT, IFRT, IMRT, NSCLC |
42 |
2016 |
Correction: Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute. |
IFI |
43 |
2016 |
Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy. |
dCRT, LNM |
44 |
2016 |
Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiation. |
LNS, PTV, PTVsrt, SBRT |
45 |
2016 |
Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study. |
3y-LC, 3y-RC, 3yOS, IMRT, NPC, SMGs |
46 |
2016 |
Elective neck management for squamous cell carcinoma metastatic to the parotid area lymph nodes. |
END, PALN, RT |
47 |
2016 |
Hypofractionated Volumetric Modulated Arc Radiotherapy with simultaneous Elective Nodal Irradiation is feasible in prostate cancer patients: A single institution experience. |
ADT, bRFS, FU, OC, PTV, SIB, VMAT, WPRT |
48 |
2016 |
IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning. |
CI, FDG-PET, IF-RT, IMRT, NTCP, PD, TCP |
49 |
2016 |
Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF). |
ENF, IFRT, NSCLC |
50 |
2016 |
Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. |
EC, IFRT, RT |
51 |
2016 |
Mapping patterns of nodal metastases in esophageal carcinoma: rethinking the clinical target volume for supraclavicular nodal irradiation. |
CTV, EC, ESCC, LN, SCV |
52 |
2016 |
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial. |
bPFS, CI, HR, HR, PSA, RT |
53 |
2016 |
Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma. |
ESCC, IFI, IMRT, LN |
54 |
2016 |
Patterns of failure after the reduced volume approach for elective nodal irradiation in nasopharyngeal carcinoma. |
NPC, RT |
55 |
2016 |
Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa. |
5-FU, CRT, DFS, DSS, ER, ESCC, MM, OS, PS, RT, SM |
56 |
2016 |
Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best? |
CI, HR, LRC, OS, RT, SND, SNSCC |
57 |
2016 |
The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. |
ENB |
58 |
2015 |
Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China. |
CTVn, EC, ESCC, JES |
59 |
2015 |
Esthesioneuroblastoma of the nasal cavity. |
RT |
60 |
2015 |
Evaluation of a 36 Gy elective node irradiation dose in anal cancer. |
RT |
61 |
2015 |
Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute. |
ESCC, IFI, MST, OS, PFS |
62 |
2015 |
Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study. |
CGE, IF, IMPT, LA, NSCLC, PTV |
63 |
2015 |
Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation? |
EC, IFI |
64 |
2015 |
Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. |
IFRT |
65 |
2015 |
Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse. |
eCRT, LF, LRF, NF, NS, tf |
66 |
2015 |
PET-CT limitations in early stage non-small cell lung cancer: to whom more aggressive approach in radiotherapy and surgery should be directed? |
NPV, NSCLC, RT, SBRT |
67 |
2015 |
Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management. |
CI, HR, pN1 |
68 |
2015 |
Spread patterns of lymph nodes and the value of elective neck irradiation for esthesioneuroblastoma. |
ENB |
69 |
2014 |
A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer. |
LN |
70 |
2014 |
Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. |
GI, GU |
71 |
2014 |
Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. |
cSCCHN, END |
72 |
2014 |
Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis. |
IFI, SCC |
73 |
2014 |
Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II-III breast cancer? A multicentre retrospective study (KROG 12-05). |
BCS, DFS, LNs, NAC, RT |
74 |
2014 |
The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation. |
--- |
75 |
2013 |
Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study. |
CHT, ESCC, LCAHRT, RT |
76 |
2013 |
Elective neck management for high-grade salivary gland carcinoma. |
cNo, END, RT |
77 |
2013 |
Involved-field radiotherapy versus elective nodal irradiation in combination with concurrent chemotherapy for locally advanced non-small cell lung cancer: a prospective randomized study. |
IFRT |
78 |
2013 |
Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT. |
IMRT, MRI, RPLNs, SCC |
79 |
2013 |
Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: implications for radiation target volume design. |
CIINF, CILRF, INF, LRF, NSCLC, OS, PORT |
80 |
2013 |
Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma. |
DFFS, IMRT, NPC, OS, RC |
81 |
2012 |
Adenoid cystic carcinoma of the head and neck. |
ACC |
82 |
2012 |
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer. |
CTV, RT |
83 |
2012 |
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry. |
--- |
84 |
2012 |
Impact of omission of elective nodal irradiation on treatment outcomes in locally advanced pancreatic adenocarcinoma patients treated with definitive concurrent chemoradiotherapy. |
CCRT, LAPAC, LRPFS, OS, PFS |
85 |
2012 |
Incidence of isolated nodal failure in non-small cell lung cancer patients included in a prospective study of the value of PET-CT. |
INF |
86 |
2012 |
Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. |
CSS, DFS, DM, LRC, LRF, OS, QOL |
87 |
2012 |
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial. |
LD-SCLC, PTV, RT |
88 |
2011 |
3D-conformal RT, fixed-field IMRT and RapidArc, which one is better for esophageal carcinoma treated with elective nodal irradiation. |
3DCRT, ESCC, IMRT, MUs, OARs |
89 |
2011 |
A phase II trial of accelerated hypofractionated three-dimensional conformal radiation therapy in locally advanced non-small cell lung cancer. |
HypoRT, LRPFS, NSCLC, OS, PFS |
90 |
2011 |
Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis. |
3DCRT, CR, CRT, SqCC |
91 |
2011 |
Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. |
IFI |
92 |
2011 |
Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study. |
GTV, NSCLC, PET, PTV |
93 |
2011 |
Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach? |
ENB |
94 |
2011 |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. |
CCRT, SCC |
95 |
2010 |
Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation. |
SCCA |
96 |
2010 |
Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. |
IFRT, NSCLC |
97 |
2009 |
Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship. |
INR, NSCLC |
98 |
2009 |
Elective nodal irradiation (ENI) does not appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC): in regard to Schild et al. (Int J Radiat Oncol Biol Phys 2008;72:335-342). |
NSCLC |
99 |
2009 |
Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. |
CR, CRT, SCC |
100 |
2009 |
Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion? |
NSCLC |
|